Table 2.
Adherence measures, at each time point overall and stratified by treatment arm. Baseline metrics were calculated among participants who were on PrEP at baseline. Metrics at 3- and 6-months are from all participants with available measures.
| SOC |
P3 |
P3+ |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| BL |
3-month |
6-month |
BL |
3-month |
6-month |
BL |
3-month |
6-month |
|
| Primary | |||||||||
| TFV | 52/74 (70.3%) | 33/50 (66.0%) | 31/51 (60.8%) | 53/74 (71.6%) | 39/50 (78.0%) | 31/51 (60.8%) | 51/73 (69.9%) | 41/53 (77.4%) | 34/58 (58.6%) |
| FTC | 50/73 (68.5%) | 29/51 (56.9%) | 24/48 (50.0%) | 60/74 (81.1%) | 36/50 (72.0%) | 31/50 (62.0%) | 53/73 (72.6%) | 38/54 (70.4%) | 31/56 (55.4%) |
| Secondary (self-report) | |||||||||
| ≥4 days, last 7 days | 63/75 (84.0%) | 51/69 (73.9%) | 47/68 (69.1%) | 71/76 (93.4%) | 58/68 (85.3%) | 49/66 (74.2%) | 60/72 (83.3%) | 59/70 (84.3%) |
48/71 (67.6%) |
| >60%, last month | 69/76 (90.8%) | 54/70 (77.1%) | 52/68 (76.5%) |
71 /75 (94.7%) | 59/69 (85.5%) | 47/66 (71.2%) |
66/72 (91.7%) | 61/70 (87.1%) | 49/71 (69.0%) |